Related Experiment Video
Updated: May 7, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Chronic HCV infection is a risk factor of ischemic stroke
Luigi E Adinolfi1, Luciano Restivo, Barbara Guerrera
1Department of Medicine, Surgery, Neurology, Geriatric and Metabolic Diseases, Second University of Naples, Internal Medicine of Clinic Hospital of Marcianise, ASL Caserta, Italy.
Insights
Hepatitis C virus (HCV) infection significantly increases stroke risk, particularly at younger ages. Inflammation appears to be a key factor, highlighting the need for clinical awareness.
Area of Science:
- Neurology
- Infectious Diseases
- Cardiovascular Medicine
Background:
- Cerebrovascular diseases, including stroke, are a major global health concern.
- Inflammation plays a critical role in the pathogenesis of atherosclerosis and stroke.
- Hepatitis C virus (HCV) infection is increasingly recognized as a risk factor for atherosclerosis due to its inflammatory effects and presence in vascular tissues.
Purpose of the Study:
- To investigate the prevalence and role of Hepatitis C virus (HCV) infection in patients diagnosed with stroke.
- To test the hypothesis that individuals with HCV infection are at an elevated risk of experiencing stroke.
Main Methods:
- A cohort study involving 820 consecutive patients, with 123 diagnosed with stroke and 697 serving as age- and gender-matched controls.
- Patients were assessed for HCV infection status and conventional stroke risk factors.
- Statistical analyses, including multivariate analysis, were employed to determine the independent risk of HCV infection for stroke.
Main Results:
- The prevalence of HCV infection was significantly higher in the stroke group (26.8%) compared to the control group (6.6%).
- HCV-positive stroke patients were younger and exhibited lower cholesterol and triglyceride levels but higher inflammatory markers (ESR, CRP, fibrinogen).
- HCV infection was identified as an independent risk factor for stroke (Odds Ratio 2.04).
Conclusions:
- Hepatitis C virus (HCV) infected individuals face a substantially higher and earlier risk of stroke.
- Inflammation is a critical mediator in the relationship between HCV infection and stroke.
- These findings necessitate increased clinical awareness and consideration of HCV status in stroke risk assessment and future research.
Objectives:
Cerebrovascular diseases are leading cause of death worldwide. Plaque rupture and embolization account for one-third of ischemic stroke. The causes are not fully known, but inflammation plays a pathogenic role. Recently, HCV infection has been identify as risk of atherosclerosis. HCV replicates within carotid plaques and brain endothelia cells; moreover, HCV patients showed higher levels of inflammation. Thus, we hypothesized that subjects carrying HCV are at higher risk of stroke. Accordingly, we evaluated prevalence and role of HCV infection in patients with stroke.
Methods:
A priori sample size was calculated. Overall, 820 consecutive patients were enrolled, 123 with stroke and, as control, 697 age- and gender-matched (295 with COPD; 402 with diseases other than HCV-associated). Patients were evaluated for HCV and conventional risk of stroke.
Results:
Prevalence of HCV was higher in patients with stroke than that observed in control (26.8% vs. 6.6%, p = 0.0001). An analysis of stroke patients showed that those HCV positive were younger (p = 0.017) had lower serum levels of cholesterol (p = 0.001), triglycerides (p = 0.045), and higher serum levels of inflammation markers (ESR, p = 0.001; CRP, p = 0.0001; fibrinogen, p = 0.012). A multivariate analysis showed that HCV infection was an independent risk factor of stroke (O.R. 2.04, 95% C.I. 1.69-2.46; p = 0.0001). A secondary analysis showed that HCV patients had higher (p = 0.031) prevalence of past ischemic heart disease.
Conclusions:
HCV infected patients are at higher and earlier risk of stroke. Inflammation is a key mediator. Clinicians in clinical practice and researchers in future trials should take into account these new findings.
Related Concept Videos
Ischemic Stroke l: Introduction
Hepatitis
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Viral Hepatitis I: Introduction
Hemorrhagic Stroke l: Introduction

